Home » Topics » BioWorld Science

BioWorld Science
RSS

ConSynance announces initiation of toxicology studies of CSTI-300 for IBS-D

May 31, 2018

DSMB clears phase II trial of AG-013 for oral mucositis to continue

May 30, 2018

FDA grants priority review to Sage's NDA for intravenous brexanolone for postpartum depression

May 30, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

Nur77-deficient mice show altered dendritic cell functioning

May 30, 2018

Antitumor efficacy seen with HERA-GITRL fusion protein from Apogenix

May 30, 2018

miR-126 and miR-223 found as potential biomarkers of cardiac sarcoidosis

May 30, 2018

FDA accepts Cabometyx sNDA for previously treated HCC

May 30, 2018

HyLeukin-7 begins U.S. trial in brain cancer

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...